Diabetes drug may prevent liver cancer

by Meredith Jackson,Vanderbilt UniversityCredit: CC0 Public DomainA drug commonly used to treat type 2 diabetes might help prevent patients from developing liver cancers.In a study published thi

Updated on: March 01,2024

Diabetes drug may prevent liver cancer

by Meredith Jackson,Vanderbilt UniversityCredit: CC0 Public DomainA drug commonly used to treat type 2 diabetes might help prevent patients from developing liver cancers.In a study published thi

Updated on:March 01,2024

Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies

byUNC Lineberger Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers at UNC Lineberger Comprehensive Cancer Center have found a possible way to overcome barriers that block

Updated on: January 04,2024

Biological pathways provide evidence for how to overcome barriers limiting cancer immunotherapies

byUNC Lineberger Comprehensive Cancer CenterCredit: Unsplash/CC0 Public DomainResearchers at UNC Lineberger Comprehensive Cancer Center have found a possible way to overcome barriers that block

Updated on:January 04,2024

AI effective in diagnosis of head and neck cancer, finds researcher

by Claes Björnberg,Umea UniversityCredit: Pixabay/CC0 Public DomainStudies in a new doctoral thesis indicate that an AI-supported method is effective in the diagnosis of squamous cell carcinoma

Updated on: February 01,2024

AI effective in diagnosis of head and neck cancer, finds researcher

by Claes Björnberg,Umea UniversityCredit: Pixabay/CC0 Public DomainStudies in a new doctoral thesis indicate that an AI-supported method is effective in the diagnosis of squamous cell carcinoma

Updated on:February 01,2024

Study may explain why once-promising cancer drugs failed

by Duke UniversityInvading cells (green) in the lab wormC. elegans(purple) can change their tactics to get around cancer drugs called MMP inhibitors and trespass into other tissues. T

Updated on: May 21,2024

Study may explain why once-promising cancer drugs failed

by Duke UniversityInvading cells (green) in the lab wormC. elegans(purple) can change their tactics to get around cancer drugs called MMP inhibitors and trespass into other tissues. T

Updated on:May 21,2024

Young women often delay looking into breast symptoms, research finds

by Dennis ThompsonYoung women who find a lump or other potential signs of breast cancer often delay for weeks before finally seeing a doctor, a new study shows.On average, young women waited two weeks

Updated on: April 28,2024

Young women often delay looking into breast symptoms, research finds

by Dennis ThompsonYoung women who find a lump or other potential signs of breast cancer often delay for weeks before finally seeing a doctor, a new study shows.On average, young women waited two weeks

Updated on:April 28,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on: March 01,2024

Study: Innovative pancreatic cancer treatment may rev up immune system

by University of Rochester Medical CenterImmune cells (orange) and blood vessels (green) inside a tumor. Credit: University of Rochester Medical CenterA University of Rochester Wilmot Cancer Inst

Updated on:March 01,2024

Trends in genitourinary cancers examined in the United States

by Elana GotkineThe highest incidence rates of bladder cancer are seen in the Northeast, while the West has the highest deaths rates for prostate cancer among non-Hispanic White men, according to a st

Updated on: January 02,2024

Trends in genitourinary cancers examined in the United States

by Elana GotkineThe highest incidence rates of bladder cancer are seen in the Northeast, while the West has the highest deaths rates for prostate cancer among non-Hispanic White men, according to a st

Updated on:January 02,2024

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on: March 06,2024

Novel pretargeted radionuclide therapy for HER2-expressing cancers shows promise

by Society of Nuclear Medicine and Molecular ImagingTransversal (A), coronal (B), sagittal (C) nanoSPECT/CT images and maximum intensity projection (D) obtained 30 h after injection of pretargeted&nbs

Updated on:March 06,2024

A new strategy 'raises the volume' of gut-body communication

by Ana María Rodríguez, Ph.d.,Baylor College of MedicineCredit: CC0 Public DomainThroughout the gastrointestinal tract there are specialized hormone-producing cells called enteroendocrine cells

Updated on: May 23,2024

A new strategy 'raises the volume' of gut-body communication

by Ana María Rodríguez, Ph.d.,Baylor College of MedicineCredit: CC0 Public DomainThroughout the gastrointestinal tract there are specialized hormone-producing cells called enteroendocrine cells

Updated on:May 23,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on: January 02,2024

The protein behind immunotherapy resistance

byEcole Polytechnique Federale de LausanneTumor with FMRP-deficient cancer cells (in green) being infiltrated and attached by killer (CD8) T cells. Credit: Jeremy Guillot (Hanahan Lab – EPFL).Im

Updated on:January 02,2024

Pattern of hospital visits offers clue to spotting people at risk of myeloma

by National Cancer Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A condition that can progress to myeloma c

Updated on: May 13,2024

Pattern of hospital visits offers clue to spotting people at risk of myeloma

by National Cancer Research InstituteMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0A condition that can progress to myeloma c

Updated on:May 13,2024

Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

by Impact Journals LLCMultiple mechanisms underly the pro-tumorigenic role of CD200. Credit: 2023 Shao and Owens.A new research perspective titled "The immunoregulatory protein CD200 as a potenti

Updated on: January 30,2024

Investigating the immunoregulatory protein CD200 as a potentially lucrative yet elusive target for cancer therapy

by Impact Journals LLCMultiple mechanisms underly the pro-tumorigenic role of CD200. Credit: 2023 Shao and Owens.A new research perspective titled "The immunoregulatory protein CD200 as a potenti

Updated on:January 30,2024